Hellenic Dynamics Plc in brief
Hellenic Dynamics Plc is a listed company in the Healthcare sector, based in the UK. Its last known market value was $590 M (January 2024); there is no current figure. Its shares trade under the symbol HELD.L (LSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Hellenic Dynamics Plc timeline
- 2007
- 🏁· approximateIncorporated as Hellenic Dynamics Plc
- 2017
- •Legal Entity Identifier issuedLEI 213800IM978BOB5QZA69 registered.
- 2022
- ✎Renamed Hellenic Dynamics PlcLegal name change recorded in the LEI register.
Events of Hellenic Dynamics Plc from the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in UK: #1,119 (Dec 2022) · #1,212 (Jul 2023) · #402 (Jan 2024)
Balance sheet
- Total assets
- $4 M
- Total liabilities
- $2 M
- Total equity
- $2 M
As of March-2023
Hellenic Dynamics Plc: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in GBP thousands; per-share figures in GBP; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2021to Dec 31, 2021 |
|---|---|---|
| Income statement | ||
| Revenue | 0—— | |
| Cost of revenue | 0—— | |
| Gross profit | 0—— | |
| General and administrative | 335—— | |
| Operating income | −335—— | |
| Income before tax | −349—— | |
| Income tax | 0—— | |
| Net income including minority interests | −349—— | |
| Earnings per share, basic | -0.00—— | |
| Balance sheet | ||
| Cash and cash equivalents | 5.0—0.5% | |
| Receivables | 168—16.4% | |
| Current assets | 173—16.8% | |
| Property, plant and equipment | 528—51.3% | |
| Right-of-use (leased) assets | 316—30.7% | |
| Other intangible assets | 8.4—0.8% | |
| Non-current assets | 855—83.2% | |
| Total assets | 1,029—100% | |
| Accounts payable | 209—20.4% | |
| Current liabilities | 264—25.7% | |
| Long-term debt | 0—0.0% | |
| Lease liabilities (non-current) | 310—30.1% | |
| Non-current liabilities | 310—30.1% | |
| Retained earnings | −680—−66.1% | |
| Total equity | 455—44.2% | |
| Total liabilities and equity | 1,029—100% | |
| Cash-flow statement | ||
| Share-based compensation | 0—— | |
| Cash from operating activities | −381—— | |
| Capital expenditure | −94—— | |
| Cash from investing activities | −87—— | |
| Debt issued | 464—— | |
| Shares issued | 0—— | |
| Cash from financing activities | 464—— | |
| Change in cash | −4.1—— | |
| Report | ESEF | |
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2021. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Hellenic Dynamics Plc🇬🇧 | $590 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Balance sheet:
- As of March-2023
- Profile updated:
- Nov 4, 2026
Figures from value.today research, GLEIF register.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Hellenic Dynamics Plc? Verify and update this profile — free
Show Hellenic Dynamics Plc's ranking on your website Get the badge
The badge updates itself as the ranking changes.